American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment. - Test2 - elhamkhani - TriplyDB

American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

http://www.wikidata.org/entity/Q35894574

about

The State of Cancer Care in America, 2016: A Report by the American Society of Clinical Oncology Increasing trends in kidney cancer over the last 2 decades in Saudi Arabia.Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute.Cancer Signature Investigation: ERBB2 (HER2)-Activating Mutation and Amplification-Positive Breast Carcinoma Mimicking Lung Primary.Is Participation in Cancer Phase I Trials Really Therapeutic?Influence of early phase clinical trial enrollment on patterns of end-of-life care for children with advanced cancer.Understanding how coping strategies and quality of life maintain hope in patients deliberating phase I trial participation.Challenges Facing Early Phase Trials Sponsored by the National Cancer Institute: An Analysis of Corrective Action Plans to Improve Accrual.Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment.Characteristics of Participants Enrolled onto a Randomized Controlled Trial of Palliative Care for Patients on Phase I Studies.Interest in initiating an early phase clinical trial: results of a longitudinal study of advanced cancer patients.Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act.Patient and family member perspectives on searching for cancer clinical trials: A qualitative interview study.Nonparametric overdose control with late-onset toxicity in phase I clinical trials.Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis.Qualitative analysis of clinical research coordinators' role in phase I cancer clinical trials.Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials?Investigator Disclosure and Advanced Cancer Patient Understanding of Informed Consent and Prognosis in Phase I Clinical Trials

P2860

Q30809363-F8A6F018-B7B2-4919-80BB-88ADDE7CB674 Q35681176-BAA88FE6-1C57-4FAB-9CD3-61A4AC777B7B Q36344469-A51BF837-8E08-41CB-97E6-E670A551B9BB Q36605624-D799C610-E9D4-42D0-9DE7-6504525A9819 Q37660474-41B5D10C-C7A3-45BD-AE71-A479228D19B7 Q38647531-B1D8C2D8-B857-4584-882D-69C76C61ED09 Q38700608-73B204FC-E424-4C6B-A675-3CFEB4A062D6 Q38843090-61B4060F-4F90-49B1-B86E-26301ECE9497 Q39610150-821F8797-40D3-4C82-8E9E-9416CEED9B3A Q41439334-50867D94-93EB-40FE-92E5-6C5F60BF4E3B Q46004796-3FA4CF78-2534-4247-B86D-D2202CBAE8A9 Q46306875-82CDBB0A-0957-47B3-9603-4F25958D9500 Q46662603-EDB5B240-233E-4396-A2F2-53630B1CD0AC Q49623381-027E517F-954C-468E-8782-BBF7D5F40F1F Q50593013-D575E6CB-759A-4D9E-A66F-96CF0646CC46 Q52692689-91D84811-90EC-42DE-81AE-2D2290726A3A Q55399727-712D3C6F-5FB2-4294-9A90-54A452427FB8 Q56520646-04FCDFDA-0506-4773-9910-255CA8F142DA Q56545806-8B3C3B7B-27C7-42BD-86BD-91075353B019

P2860

American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

http://www.wikidata.org/entity/Q35894574

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

American Society of Clinical O ...... cancer research and treatment.

@ast

American Society of Clinical O ...... cancer research and treatment.

@en

type

label

American Society of Clinical O ...... cancer research and treatment.

@ast

American Society of Clinical O ...... cancer research and treatment.

@en

prefLabel

American Society of Clinical O ...... cancer research and treatment.

@ast

American Society of Clinical O ...... cancer research and treatment.

@en

P1433

Q35894574-468AEAD6-B82A-4B7E-90AD-3265FF23EF86

P1476

Q35894574-C20B7E45-1370-4541-9635-B1B25D7C5589

P2093

Q35894574-3743D519-8B67-4399-A5D2-82055BB492E3

Q35894574-67C161B7-B102-4371-AEF0-23F59D4B86A2

Q35894574-6A17B13F-6992-4D29-A345-1983AEA9226C

Q35894574-83FA0849-67E8-44D1-A6C9-90FA32CD8A2B

Q35894574-8E676D66-73FC-4984-B3E5-DFCC47516E6D

Q35894574-92E886F9-29CA-48F0-A657-9343196CD606

Q35894574-9C49394A-9E59-4B68-8FC2-74BDB2E8206B

Q35894574-ACC8AB4C-F30E-4BCA-858A-8518C54C9DC1

Q35894574-AD60BE00-8916-40C7-BADD-18719373CE9E

Q35894574-DE1BC7DC-40F8-4E1F-8E58-C0BB845FFE8B

P2860

Q35894574-011E0348-8024-493F-A5BF-017DECEC8E2C

Q35894574-07132C28-DDE6-40BB-9E2C-05F7DC952D6A

Q35894574-081B5F5B-2666-40AB-ABAA-33DC89F857F9

Q35894574-08C67282-0BE2-4651-AB01-2C9A26DC70FE

Q35894574-0E96ADB5-11B9-42F0-BDFE-BF6FB0282C49

Q35894574-1361AF29-9C93-4CB0-91A6-2C7804C7408D

Q35894574-13F1337C-C653-441C-B911-4EE4135D7737

Q35894574-16F1E2C5-47AC-4037-960C-6472CFC4EA20

Q35894574-17F890E2-70BC-4672-AC8E-ED92C258F60A

Q35894574-19414E8F-2DD4-4936-9145-A1F0FDDDD4E3

P304

Q35894574-B58E97DA-65A5-40DA-9E82-B6BE548F29DE

P31

Q35894574-366B5B2F-89EF-4115-B9BC-579C348D808A

P356

Q35894574-556190C5-7DB7-49F4-B4C6-52E288C0C62D

P407

Q35894574-E220881C-75C3-464D-B0B5-54B5581E276F

P433

Q35894574-C8D5DC96-12E0-4C35-B35D-A7FD64A64F0D

P478

Q35894574-CA6E5934-75BE-4EDC-9D7D-2231B03BFC5F

P50

Q35894574-2649E35B-CCAB-4B3B-923C-A84387A44A57

Q35894574-9A550F8C-A91D-4367-BDE6-B72A1D3CE8FB

Q35894574-FD77B96C-1A1D-4990-A70A-364879CC5358

P577

Q35894574-7D5A413F-A128-4F3A-9DEC-83AEA1B81776

P698

Q35894574-95701A23-177F-485E-8001-88B942C4CC9D

P921

Q35894574-FC9F0852-1A66-4567-AA9F-C81634BE975E

P932

Q35894574-3A42FCCB-79E7-4764-8359-2C20D336E003

P356

JCO.2014.58.2635

P1433

Journal of Clinical Oncology

P1476

American Society of Clinical O ...... cancer research and treatment.

@en

P2093

David M Waterhouse

http://www.w3.org/2001/XMLSchema#string

Howard A Burris

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Weber

http://www.w3.org/2001/XMLSchema#string

Laura A Levit

http://www.w3.org/2001/XMLSchema#string

Lynn M Schuchter

http://www.w3.org/2001/XMLSchema#string

Michael A Carducci

http://www.w3.org/2001/XMLSchema#string

Michael A Postow

http://www.w3.org/2001/XMLSchema#string

Michael A Thompson

http://www.w3.org/2001/XMLSchema#string

Mithat Gönen

http://www.w3.org/2001/XMLSchema#string

Peter C Adamson

http://www.w3.org/2001/XMLSchema#string

P2860

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours

Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group

Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus)

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Clinical trial designs for cytostatic agents: are new approaches needed?

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

Ethics of phase 1 oncology studies: reexamining the arguments and data.

P304

278-284

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2014.58.2635

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Suanna S Bruinooge

P577

2014-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25512456

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

P932

4516884

http://www.w3.org/2001/XMLSchema#string